Michael Baum Selected Research

Michael Baum Research Topics

Disease

54	Breast Neoplasms (Breast Cancer) 01/2021 - 10/2000
24	Neoplasms (Cancer) 12/2020 - 10/2002
4	Wounds and Injuries (Trauma) 01/2020 - 06/2002
3	Ductal Carcinoma 01/2020 - 02/2014
2	Triple Negative Breast Neoplasms 01/2020 - 07/2012
2	Neoplasm Micrometastasis 01/2013 - 07/2012
2	Inflammation (Inflammations) 01/2013 - 07/2012
1	Disease Resistance 01/2022
1	Acute Disease 12/2020
1	Tetraploidy 01/2020
1	Hypertension (High Blood Pressure) 03/2015
1	Renal Cell Carcinoma (Grawitz Tumor) 03/2015
1	Melanoma (Melanoma, Malignant) 12/2010
1	Lung Neoplasms (Lung Cancer) 12/2010
1	Endometrial Neoplasms (Endometrial Cancer) 12/2010
1	Ovarian Neoplasms (Ovarian Cancer) 12/2010
1	Exanthema (Rash) 09/2010
1	Lobular Carcinoma 07/2010
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 02/2008
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2008
1	Starvation 01/2007
1	Hodgkin Disease (Hodgkin's Disease) 02/2005
1	Osteoporotic Fractures 07/2004
1	Body Odor 05/2002

Drug/Important Bio-Agent (IBA)

13	Tamoxifen FDA LinkGeneric 12/2020 - 01/2002
10	Hormones (Hormone)IBA 12/2020 - 10/2002
8	Anastrozole (Arimidex)FDA LinkGeneric 11/2011 - 05/2003
4	Biological ProductsIBA 01/2021 - 10/2002
4	Aromatase InhibitorsIBA 01/2010 - 05/2003
2	Pharmaceutical PreparationsIBA 01/2020 - 01/2002
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2020 - 07/2012
2	KetorolacIBA 01/2020 - 07/2012
2	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2013 - 07/2012
2	Analgesics (Analgesic Drugs)IBA 01/2013 - 07/2012
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2010 - 10/2005
2	Estrogen ReceptorsIBA 01/2010 - 10/2005
2	Letrozole (Femara)FDA LinkGeneric 04/2006 - 05/2003
2	Estrogens (Estrogen)FDA Link 07/2004 - 05/2002
1	Leucine (L-Leucine)FDA Link 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Guanosine Diphosphate (GDP)IBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2015
1	Axitinib (AG 013736)IBA 03/2015
1	Sorafenib (BAY 43-9006)FDA Link 03/2015
1	Antihypertensive Agents (Antihypertensives)IBA 03/2015
1	Anesthetics (Anesthetic Agents)IBA 01/2013
1	Dihydrotachysterol (AT 10)IBA 07/2012
1	Detergents (Detergent)IBA 09/2010
1	Metronidazole (Metric)FDA LinkGeneric 09/2010
1	Minocycline (Cyclops)FDA LinkGeneric 09/2010
1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2010
1	nadifloxacinIBA 09/2010
1	Cetuximab (Erbitux)FDA Link 09/2010
1	RNA (Ribonucleic Acid)IBA 04/2010
1	Goserelin (Zoladex)FDA Link 03/2009
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 03/2009
1	romidepsin (FK228)FDA Link 02/2008
1	Histone Deacetylase InhibitorsIBA 02/2008
1	DepsipeptidesIBA 02/2008
1	CopperIBA 01/2007
1	IronIBA 01/2007
1	NitrogenIBA 01/2007
1	Phosphotransferases (Kinase)IBA 01/2007
1	SulfurIBA 01/2007
1	OligonucleotidesIBA 02/2005
1	RNA IsoformsIBA 02/2005
1	Protein Isoforms (Isoforms)IBA 02/2005
1	RNA Splicing FactorsIBA 02/2005
1	Mitogen-Activated Protein Kinase 9IBA 02/2005
1	Proteins (Proteins, Gene)FDA Link 02/2005
1	Megestrol Acetate (Borea)FDA LinkGeneric 05/2003
1	exemestane (Aromasin)FDA Link 05/2003
1	TungstenIBA 06/2002
1	AndrogensIBA 05/2002
1	Oral ContraceptivesIBA 10/2000

Therapy/Procedure

27	Radiotherapy 01/2021 - 04/2002
16	Therapeutics 12/2020 - 01/2002
12	Segmental Mastectomy (Lumpectomy) 01/2021 - 04/2005
5	Complementary Therapies (Alternative Medicine) 02/2010 - 08/2006
4	Mastectomy (Mammectomy) 01/2020 - 07/2012
2	Drug Tapering 03/2015 - 09/2010
1	Adjuvant Radiotherapy 01/2020
1	Adjuvant Chemotherapy 12/2007
1	Conservative Treatment 06/2002
1	Chemoprevention 01/2002
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 10/2000